Kevin Fischbeck
Stock Analyst at B of A Securities
(4.13)
# 355
Out of 4,814 analysts
162
Total ratings
65.81%
Success rate
5.17%
Average return
Main Sectors:
Stocks Rated by Kevin Fischbeck
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHC Acadia Healthcare Company | Maintains: Buy | $50 → $45 | $23.91 | +86.11% | 6 | Feb 28, 2025 | |
| HCA HCA Healthcare | Maintains: Buy | $380 → $370 | $334.38 | +10.65% | 9 | Jan 27, 2025 | |
| HUM Humana | Upgrades: Neutral | $247 → $308 | $264.38 | +16.50% | 14 | Nov 6, 2024 | |
| ARDT Ardent Health Partners | Downgrades: Neutral | $22 → $19 | $12.51 | +51.88% | 2 | Nov 6, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $675 → $650 | $454.11 | +43.14% | 21 | Oct 16, 2024 | |
| AMN AMN Healthcare Services | Downgrades: Underperform | $65 → $48 | $18.50 | +159.46% | 4 | Oct 7, 2024 | |
| AGL agilon health | Downgrades: Underperform | $3 | $4.00 | -24.91% | 2 | Oct 2, 2024 | |
| DVA DaVita | Maintains: Underperform | $139 → $145 | $140.00 | +3.57% | 12 | Aug 7, 2024 | |
| ELV Elevance Health | Downgrades: Neutral | $646 → $530 | $424.53 | +24.84% | 3 | Jul 18, 2024 | |
| MOH Molina Healthcare | Downgrades: Underperform | $439 | $322.37 | +36.18% | 15 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6.5 | $7.82 | -16.88% | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.25 | $19.43 | -62.69% | 3 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $79 → $72 | $60.68 | +18.66% | 11 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $350 | $330.19 | +6.00% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $183 | $174.51 | +4.87% | 14 | Jul 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $42 → $45 | $21.22 | +112.06% | 7 | Jun 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $69 → $74 | $103.53 | -28.52% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $7.5 → $5.5 | $2.42 | +127.74% | 10 | Jun 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $16.42 | +113.15% | 7 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $10 | $3.60 | +177.78% | 2 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $45 → $50 | $121.51 | -58.85% | 4 | Jan 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7.5 | $14.27 | -47.44% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $32.26 | -44.20% | 1 | Jun 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $12.87 | - | 3 | Sep 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $19 | $28.99 | -34.46% | 2 | Feb 9, 2018 |
Acadia Healthcare Company
Feb 28, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $23.91
Upside: +86.11%
HCA Healthcare
Jan 27, 2025
Maintains: Buy
Price Target: $380 → $370
Current: $334.38
Upside: +10.65%
Humana
Nov 6, 2024
Upgrades: Neutral
Price Target: $247 → $308
Current: $264.38
Upside: +16.50%
Ardent Health Partners
Nov 6, 2024
Downgrades: Neutral
Price Target: $22 → $19
Current: $12.51
Upside: +51.88%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $675 → $650
Current: $454.11
Upside: +43.14%
AMN Healthcare Services
Oct 7, 2024
Downgrades: Underperform
Price Target: $65 → $48
Current: $18.50
Upside: +159.46%
agilon health
Oct 2, 2024
Downgrades: Underperform
Price Target: $3
Current: $4.00
Upside: -24.91%
DaVita
Aug 7, 2024
Maintains: Underperform
Price Target: $139 → $145
Current: $140.00
Upside: +3.57%
Elevance Health
Jul 18, 2024
Downgrades: Neutral
Price Target: $646 → $530
Current: $424.53
Upside: +24.84%
Molina Healthcare
Apr 1, 2024
Downgrades: Underperform
Price Target: $439
Current: $322.37
Upside: +36.18%
Nov 8, 2023
Downgrades: Underperform
Price Target: $6.5
Current: $7.82
Upside: -16.88%
Nov 2, 2023
Downgrades: Neutral
Price Target: $7.25
Current: $19.43
Upside: -62.69%
Sep 5, 2023
Upgrades: Neutral
Price Target: $79 → $72
Current: $60.68
Upside: +18.66%
Aug 4, 2023
Maintains: Buy
Price Target: $320 → $350
Current: $330.19
Upside: +6.00%
Jul 27, 2023
Maintains: Buy
Price Target: $183
Current: $174.51
Upside: +4.87%
Jun 2, 2023
Upgrades: Buy
Price Target: $42 → $45
Current: $21.22
Upside: +112.06%
Apr 28, 2023
Maintains: Buy
Price Target: $69 → $74
Current: $103.53
Upside: -28.52%
Jun 15, 2022
Downgrades: Neutral
Price Target: $7.5 → $5.5
Current: $2.42
Upside: +127.74%
Jan 18, 2022
Maintains: Buy
Price Target: $40 → $35
Current: $16.42
Upside: +113.15%
Jun 10, 2021
Downgrades: Underperform
Price Target: $10
Current: $3.60
Upside: +177.78%
Jan 5, 2021
Upgrades: Buy
Price Target: $45 → $50
Current: $121.51
Upside: -58.85%
Oct 8, 2020
Initiates: Underperform
Price Target: $7.5
Current: $14.27
Upside: -47.44%
Jun 24, 2020
Initiates: Buy
Price Target: $18
Current: $32.26
Upside: -44.20%
Sep 6, 2019
Downgrades: Underperform
Price Target: n/a
Current: $12.87
Upside: -
Feb 9, 2018
Maintains: Buy
Price Target: $23 → $19
Current: $28.99
Upside: -34.46%